We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App





Scientists Use Cloud-Based Supercomputing and AI to Develop COVID-19 Treatments and Vaccine Models

By HospiMedica International staff writers
Posted on 16 Sep 2020
A team of scientists from a vaccination biotech company have used cloud-based supercomputing and artificial intelligence (AI) to develop COVID-19 treatments and vaccine models.

The research team from Vaxine Pty Ltd. (Adelaide, Australia) used computer modelling on the coronavirus spike protein to rapidly design a synthetic COVID-19 vaccine. The Vaxine team was able to design, manufacture and advance their Covax-19 vaccine into human trials in under five months in a process that normally would take up to 15 years. The team is also using similar techniques for other projects, including a new treatment for respiratory complications of COVID-19, a preventive nasal spray, and a rapid response test to predict how severely the disease will progress.

Recently, the Vaxine research group released a list of up to 80 new potential candidate drugs against the COVID-19 virus. The possible therapies were identified using cloud-based supercomputer programs used by Vaxine in its vaccination research modelling, allowing other researchers to further investigate their potential. Using the genetic sequence of COVID-19, the team built three dimensional molecular structures of key COVID-19 proteins that were then used to screen existing drugs and natural remedies for potential activity against the COVID-19 protease protein. The team used high performance cloud computing services provided by Oracle under a research grant to Flinders University (Adelaide, South Australia) that enabled the team to rapidly screen for potential drugs against COVID-19.

“Thanks to our unique ability to run computer simulations on the virus before it is even fully characterized, we were able to dramatically speed up the ability to design our Covax-19 vaccine,” said Flinders University Professor Nikolai Petrovsky, Research Director of Vaxine. “The vaccine based on the synthetic spike protein was then manufactured in insect cell cultures before being combined with our Vaxine Advax adjuvant, which is used to turbocharge the vaccine and make it more effective.”

“It is exciting to be at the forefront of global COVID-19 science efforts, applying all the latest cutting edge methods including artificial intelligence and high performance cloud computing to create potential pandemic drugs and vaccines as part of the Vaxine team,” said Dr. Sakshi Piplani, who leads Vaxine’s bioinformatics team.

Related Links:
Vaxine Pty Ltd.
Flinders University



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Body Composition Analyzer
seca mBCA Pro
New
Auditory Evoked Potential Device
Bio-logic NavPRO ONE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The novel approach utilizes continuous glucose monitoring to detect early signs of impaired glucose regulation (Photo courtesy of Shinya Kuroda/University of Tokyo)

Wearable Glucose Monitor Offers Less Invasive Approach to Assessing Diabetes Risk

Diabetes, often referred to as a "silent epidemic," is a growing global health issue with significant impacts on both health and the economy. Detecting impaired glucose regulation early — an intermediate... Read more

Surgical Techniques

view channel
Image: The Elana Heart Bypass System is designed to make suturing obsolete (Photo courtesy of AMT Medical)

Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures

In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.